Clinical Trial Update: Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

View source ↗

Summary

A completed clinical trial update on preventing cardiovascular events in patients with high to very high risk dyslipidemia; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cardiovascular Diseases
• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• Daiichi Sankyo Europe, GmbH product

Snippet

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Conditions: Dyslipidemia, Cardiovascular Diseases | Status: COMPLETED | Results posted: 2024-02-20